An Angiogenesis Inhibitor from Marine-Derived Actinomycete, Nocadiopsis sp.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mojid Mondol | - |
dc.contributor.author | 한종우 | - |
dc.contributor.author | 김지혜 | - |
dc.contributor.author | 이희승 | - |
dc.contributor.author | 이연주 | - |
dc.contributor.author | 권호정 | - |
dc.contributor.author | 신희재 | - |
dc.date.accessioned | 2020-07-16T22:30:21Z | - |
dc.date.available | 2020-07-16T22:30:21Z | - |
dc.date.created | 2020-02-11 | - |
dc.date.issued | 2009-10-15 | - |
dc.identifier.uri | https://sciwatch.kiost.ac.kr/handle/2020.kiost/29330 | - |
dc.description.abstract | An angiogenesis inhibitor was isolated from the culture broth of Nocariopsis sp. which was obtained from a seaseed samploe collected from Arctic. This compound showed anti-angiogenesis activity against human umbilical vein endothellial cells (HUVECs). The structure of this compound was determined by MS, 1D and 2D NMR spectral data analysis. The relative stereochemistry of this compound was determined by Marfesy's method. | - |
dc.description.uri | 2 | - |
dc.language | English | - |
dc.publisher | 대한약학회 | - |
dc.relation.isPartOf | The Pharmaceutical Society of Korea | - |
dc.title | An Angiogenesis Inhibitor from Marine-Derived Actinomycete, Nocadiopsis sp. | - |
dc.type | Conference | - |
dc.citation.conferencePlace | KO | - |
dc.citation.endPage | 194 | - |
dc.citation.startPage | 194 | - |
dc.citation.title | The Pharmaceutical Society of Korea | - |
dc.contributor.alternativeName | 김지혜 | - |
dc.contributor.alternativeName | 이희승 | - |
dc.contributor.alternativeName | 이연주 | - |
dc.contributor.alternativeName | 신희재 | - |
dc.identifier.bibliographicCitation | The Pharmaceutical Society of Korea, pp.194 | - |
dc.description.journalClass | 2 | - |